The largest database of trusted experimental protocols

Ficoll histopaque 1077

Manufactured by Merck Group
Sourced in United States, Germany, United Kingdom, Italy, France

Ficoll Histopaque-1077 is a sterile, endotoxin-tested solution used for the isolation of mononuclear cells from blood. It is a density gradient medium that separates blood components based on their density differences during centrifugation.

Automatically generated - may contain errors

100 protocols using ficoll histopaque 1077

1

Isolation of PBMCs from Human Blood

Check if the same lab product or an alternative is used in the 5 most similar protocols
We collected 40 ml peripheral blood samples from the median cubital vein following WHO guidelines on drawing blood
17
. From freshly drawn heparinized blood, we isolated peripheral blood mononuclear cells (PBMCs) using Ficoll Histopaque 1077 (Sigma-Aldrich, USA). Briefly, peripheral blood was diluted 1:1 with phosphate buffer saline (PBS) + 2% fetal bovine serum (FBS) to a total volume of 30–35 ml. It was then carefully layered into 20 ml of Ficoll Histopaque 1077 (Sigma-Aldrich, USA) in a 50 ml conical tube. Subsequently, the tube was put into a centrifuge at 300xg for 30 minutes. The PBMC layer was obtained in the form of a buffy coat layer. Using a sterile plastic pipette, the PBMCs were carefully taken and put into another 50 ml conical tube. Furthermore, PBMC was added with PBS + 2% FBS in a ratio of 1: 1, then stirred until homogeneous and centrifuged at 300xg for 7 minutes. This step was repeated with the supernatant removed, 15 ml of PBS + 2% FBS was added to the precipitate formed at the bottom of the tube and centrifuged at 300xg for 7 minutes. Finally, the supernatant was removed, and the sediment was dissolved with a basal medium. Cells were concentrated up to 5×10
6 cells/ml.
+ Open protocol
+ Expand
2

PBMC Isolation from Whole Blood

Check if the same lab product or an alternative is used in the 5 most similar protocols
Twenty mL of blood was collected from each participant by venipuncture. Approximately 16 mL of blood were collected in heparinized tubes (Vacutainer, BD) for PBMC purification and 4 mL in EDTA tubes for plasma and DNA isolation. Blood was diluted 1:1 with Dulbecco’s phosphate-buffered saline (DPBS) pH 7.4 (KCl 2.67 mM, KH2PO4 1.47 mM, NaCl 137.93 mM, Na2HPO4 8.06 mM) and mononuclear cell layer was separated using Ficoll histopaque-1077® (Sigma, USA) density gradient. Fresh PBS/heparinized blood was added to a Ficoll-histopaque solution at 2:1 proportion and centrifuged at 400 x g for 40 min. PBMCs were collected and washed twice with PBS pH 7.4. Cells were suspended in complete RPMI-1640 medium (RPMIc) (Gibco, USA) containing antibiotics, non-essential amino acids and 10% Fetal Bovine Serum (FBS).
+ Open protocol
+ Expand
3

Jurkat and Primary T Cell Labeling and Transduction

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Jurkat T cell line was obtained commercially (#TIB-152, ATCC, Manassas, VA) for initial nanoemulsion cell labeling characterizations. Jurkat cells were grown in RPMI-1640 media (Gibco, Waltham, MA) plus 10% fetal bovine serum (FBS), 10 mM HEPES buffer (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), 1 mM sodium pyruvate and 1.5 mg/mL sodium bicarbonate.
Primary human T cells were obtained from blood samples sourced from the San Diego Blood Bank and enriched for T cells by Ficoll (Histopaque 1077, Sigma Aldrich) gradient density centrifugation and magnetic assisted cell sorting (Dynabeads, Thermo Fisher). T-cells were then activated with human T-activator CD3/CD28 Dynabeads and allowed to expand for two days in RPMI-1640 supplemented with 10% FBS and 100 units/mL of recombinant human interleukin 2 (IL-2, Peprotech, Rocky Hill, NJ). For transduction, we employed a vector specific to epidermal growth factor receptor variant III (EGFR-vIII) as described by Johnson et al. (30 ). A detailed CAR virus production and human T cell transduction is available elsewhere (31 (link)). CAR receptor expression was confirmed by flow cytometry. We used T cell populations with >70% CAR+ expression.
+ Open protocol
+ Expand
4

Isolation of Human CD14+ Monocytes from Peripheral Blood

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human CD14+ monocytes were isolated from total peripheral blood mononuclear cells of healthy donors, by immunomagnetic cell sorting. Samples from healthy donor subjects were obtained within a clinical protocol (n°463-2021), approved by the institutional Ethical Committee at IRCCS MultiMedica Milano, Milan, Italy, in accordance with the Helsinki Declaration of 1975 as revised in 2013. 30 ml of whole blood (<1 h old), collected into EDTA tubes, were subjected to Ficoll Histopaque®-1077 (Sigma-Aldrich, Inc., Saint Louis, MO, United States) density gradient stratification at 800 × g, for 25 min, room temperature (RT). The white ring interface, enriched in mononuclear cells, was collected and washed in PBS at 300 × g for 5 min, RT. Residual red blood cells were removed by treating the cell pellets with 1X Red blood lysis buffer solution (10X stock solution: NH4Cl 83g, KHCO3 10 g, EDTA 1 mM, pH 7.2–7.4 in 1 L of H2O), incubated for 10 min at 4°C and then washed in PBS at 300 × g for 5 min, RT. Monocytes were purified from PBMCs by immunomagnetic cell sorting (positive selection) using CD14 MicroBeads UltraPure (Miltenyi Biotec, Auburn, CA, United States) according to the manufacturer’s instructions.
+ Open protocol
+ Expand
5

Isolation of Human Mononuclear Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Twelve milliliters of heparinized whole blood, collected from healthy donors, was diluted with PBS 1:1 (v/v), then subjected to a density gradient stratification with Ficoll Histopaque-1077 (Sigma Aldrich, St. Louis, MO, USA) at 500× g for 20 min. The white ring interface, composed of total mononuclear cells (MNCs), was collected, washed twice in PBS, then used for subsequent experiments for NK cell polarization and treatments. Human samples were collected from healthy donors, enrolled within studies approved by the institutional review board ethics committees (protocol no. 0024138 04/07/2011, University of Insubria, Italy and protocol no. 10 2 10/2011, IRCCS MultiMedica, Milan, Italy) and according to the Helsinki Declaration of 1975 as revised in 2013. All subjects included in the study signed the informed consent, in accordance with the Helsinki Declaration of 1975 as revised in 2013.
+ Open protocol
+ Expand
6

Culturing Human Immune and Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cell lines used were human peripheral blood mononuclear cells (PBMC); Sk-Mel-19, Sk-Mel-28, Sk-Mel-103 human melanoma cells; B16F10-Nex2 murine melanoma cells; and K562 and Jurkat leukemic cells. For PBMC, B16F10-Nex2, K562, and Jurkat cells, RPMI medium was used. SK-Mel cell lines were cultured in DMEM high glucose medium. All (except PBMC) were kept in bottles containing their respective culture media and supplemented with 10% fetal bovine serum for the other strains, added 1% antibiotic (penicillin/streptomycin) at 10 mg/mL, conditioned in an incubator at 37 °C and 5% CO2.
For the preparation of human peripheral blood mononuclear cells (PBMC), human peripheral blood from a donor was collected in tubes containing sodium citrate anticoagulant. PBMC were isolated with Ficoll Histopaque-1077 (1.077 g/cm3) (Sigma Aldrich) according to the manufacturer’s instructions. The use of human blood was approved by the Ethics Committee of the Universidade Federal da Grande Dourados (UFGD) under protocol number 123/12.
+ Open protocol
+ Expand
7

PBMC-Yeast Interaction Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human PBMCs from venous blood were isolated using Ficoll-Histopaque-1077 (Sigma) and gradient centrifugation as described [33 (link)]. The PBMC-yeast interactions were carried out in round-bottom 96-well plates containing aliquots of 100 μL of 5 × 106 PBMCs/mL in RPMI 1640 Dutch modification (added with 2 mM glutamine, 0.1 mM pyruvate, and 0.05 mg/mL gentamycin; all reagents from Sigma), and 100 μL of 1 × 106 yeast cells/mL. The interactions were incubated for 24 h at 37 °C with 5% (v/v) CO2, plates were centrifuged for 10 min at 874× g and 4 °C; the supernatants were recollected and kept at −20 °C until used [36 (link)]. The concentration of TNF-α, IL-6, and IL-10 was quantified by ELISA using the kit ABTS ELISA Development from Peprotech (Rocky Hill, NJ, USA). Mock reactions where the fungal cells were not added to the interactions were included as controls. In some experiments, PBMCs were pre-incubated for 1 h at 37 °C with 200 μg/mL laminarin (Sigma) before interaction with fungal cells.
+ Open protocol
+ Expand
8

Isolation and Cryopreservation of Human Neutrophils

Check if the same lab product or an alternative is used in the 5 most similar protocols
Neutrophils were isolated from whole blood in CPTTM tubes as previously described (Heit et al., 2006 (link); Lindblom et al., 2018 (link)). Briefly, whole blood was subjected first to dextran sedimentation using 6% Dextran/0.9% NaCl solution at room temperature for 45-60 min. Supernatant containing neutrophils and mononuclear cells was transferred to a conical tube and centrifuged for 12 min at 300 RCF, 4°C with low brake. Neutrophils and mononuclear cells were separated from the erythrocyte-rich pellet by lysing erythrocytes with Ammonium-Chloride-Potassium (ACK) Lysing buffer (ThermoFisher). The pellet was resuspended in phosphate buffered saline (PBS) and the cell suspension was layered over Ficoll-Histopaque-1077 (Catalog No.1077, Sigma) and centrifuged for 30 min at 450 RCF, room temperature, low brake. After centrifugation, PBMCs were removed, and the pellet that contained neutrophils was further processed. Neutrophils were rinsed with 4 mL of Hanks’ Balance Salt Solution (HBSS), centrifuged at 450 RCF for 5 min and resuspended in 2 mL HBSS. Cell count and viability data were obtained using the MUSE cell analyzer system (Millipore). Cells were cryopreserved using 30% dimethyl sulfoxide (DMSO) in RPMI medium and thawed for later use following a previously reported protocol (Milani et al., 2016 (link)). A flowchart of the methods is shown in the Supplementary Figure S1.
+ Open protocol
+ Expand
9

Standardized Cytofluorimetric Analysis of Blood Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cytofluorimetric analysis was performed at Siena University respiratory diseases laboratory in the period April 2020 to April 2021. Briefly, the peripheral blood samples were collected and processed within 8 h Ficoll density gradient separation was performed through Ficoll Histopaque®-1077 (Sigma-Aldrich, Burlington, MA, USA) as previously reported Live cell counts were performed in a Burker chamber. Aliquots of 3 × 106 cells were stored in liquid nitrogen in a standardised manner as previously reported [26 (link),27 (link),28 (link),29 (link),30 (link)]. All experiments were performed after thawing under the same conditions.
+ Open protocol
+ Expand
10

Mononuclear Cell Isolation and RNA Extraction

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mononuclear cells, including leukemic blasts, were separated from BM or PB samples on a Ficoll–Histopaque 1077 (Sigma-Aldrich Company, Saint Louis, MO, USA) density gradient. Total RNA was extracted using RNeasy mini kit following the manufacturer's protocol (Qiagen, Hilden, Germany). The RT step was adapted from the BIOMED 1 protocol.[4 (link)] Samples were incubated for 10 min at 20°C, 45 min at 42°C, and 3 min at 99°C, followed by 10 min at 4°C.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!